Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of a bivalent inactivated enterovirus vaccine in children 6-71 months old
CTR20244635Phase 3Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent enterovirus vaccine (CA16/EV71), inactivated, sponsored by Sinovac Biotech Ltd.. Started Dec 2024; status: active.
02
Drugs
bivalent enterovirus vaccine (CA16/EV71), inactivated
Beyond the preview
Go deeper on CTR20244635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244635.